An Outcomes Comparison Between Holmium Laser Enucleation of the Prostate, Open Simple Prostatectomy, and Robotic Simple Prostatectomy for Large Gland Benign Prostatic Hypertrophy

To compare perioperative outcomes between Holmium laser enucleation of the prostate (HoLEP), open simple prostatectomy (OSP), and robotic simple prostatectomy (RSP) for large prostates (> 80 cc). A retrospective study of 340 patients who underwent HoLEP (n = 209), OSP (n = 66), or RSP (n = 65) at...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Urology (Ridgewood, N.J.) N.J.), 2023-03, Vol.173, p.180-186
Hauptverfasser: Lee, Matthew S., Assmus, Mark A., Ganesh, Meera, Han, Josh, Helon, Jessica, Mai, Quan, Mi, Xinlei, Krambeck, Amy E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 186
container_issue
container_start_page 180
container_title Urology (Ridgewood, N.J.)
container_volume 173
creator Lee, Matthew S.
Assmus, Mark A.
Ganesh, Meera
Han, Josh
Helon, Jessica
Mai, Quan
Mi, Xinlei
Krambeck, Amy E.
description To compare perioperative outcomes between Holmium laser enucleation of the prostate (HoLEP), open simple prostatectomy (OSP), and robotic simple prostatectomy (RSP) for large prostates (> 80 cc). A retrospective study of 340 patients who underwent HoLEP (n = 209), OSP (n = 66), or RSP (n = 65) at a large academic medical center between January 2013 – September 2021 was performed. Length of stay (LOS), operative time, catheter duration, estimated blood loss (EBL), blood transfusion, and 30-day ED visits and readmissions were compared between the three groups. Univariate analyses consisted of ANOVA with Tukey's corrections and Chi-square tests. Linear and multivariate logistic regression was also performed. All tests were two-sided and a p-value
doi_str_mv 10.1016/j.urology.2022.12.018
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2759961718</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0090429522010822</els_id><sourcerecordid>2759961718</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-b1aa7f5d044cd5318f67d06d72fea4f256ec8811ea2db136b5758983aac3cda03</originalsourceid><addsrcrecordid>eNqFkc9u1DAQxi0EokvhEUA-cmiC7cROckLtqnSRVlrEn7Pl2JOtV0kcbKcor8UT4mW3cEHiNNLo9803Mx9CrynJKaHi3SGfvevdfskZYSynLCe0foJWlLMqa5qGP0UrQhqSlazhF-hFCAdCiBCieo4uCsFrUbJqhX5ej3g3R-0GCHjthkl5G9yIbyD-ABjxxvWDnQe8VQE8vh1n3YOKNhGuw_Ee8CfvQlQRrvBuSvwXO0z9366ObliusBoN_uxaF63-J4E755OF3wO-64_wDYx2Pz5CSbVZJvDRu-l-eYmedaoP8OpcL9G3D7df15tsu7v7uL7eZjqdF7OWKlV13JCy1IYXtO5EZYgwFetAlR3jAnRdUwqKmZYWouUVr5u6UEoX2ihSXKK3p7mTd99nCFEONmjo04Lg5iBZxZtG0IrWCeUnVKeFg4dOTt4Oyi-SEnmMSx7kOS55jEtSJslv3ZuzxdwOYP6oHvNJwPsTAOnQBwteBm1h1GCsT6-Txtn_WPwCibmt6A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2759961718</pqid></control><display><type>article</type><title>An Outcomes Comparison Between Holmium Laser Enucleation of the Prostate, Open Simple Prostatectomy, and Robotic Simple Prostatectomy for Large Gland Benign Prostatic Hypertrophy</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Lee, Matthew S. ; Assmus, Mark A. ; Ganesh, Meera ; Han, Josh ; Helon, Jessica ; Mai, Quan ; Mi, Xinlei ; Krambeck, Amy E.</creator><creatorcontrib>Lee, Matthew S. ; Assmus, Mark A. ; Ganesh, Meera ; Han, Josh ; Helon, Jessica ; Mai, Quan ; Mi, Xinlei ; Krambeck, Amy E.</creatorcontrib><description>To compare perioperative outcomes between Holmium laser enucleation of the prostate (HoLEP), open simple prostatectomy (OSP), and robotic simple prostatectomy (RSP) for large prostates (&gt; 80 cc). A retrospective study of 340 patients who underwent HoLEP (n = 209), OSP (n = 66), or RSP (n = 65) at a large academic medical center between January 2013 – September 2021 was performed. Length of stay (LOS), operative time, catheter duration, estimated blood loss (EBL), blood transfusion, and 30-day ED visits and readmissions were compared between the three groups. Univariate analyses consisted of ANOVA with Tukey's corrections and Chi-square tests. Linear and multivariate logistic regression was also performed. All tests were two-sided and a p-value &lt;0.05 was pre-determined to be statistically significant. Analyses were performed with SAS v9.4. HoLEP was found to have the shortest: operative time (1.4 vs 2.7 vs 3.8h), LOS (0.65 vs 4.2 vs 2.6d), and catheter duration (0.38 vs 9.9 vs 11.2d) compared to OSP and RSP, respectively (all P &lt;.0001). HoLEP also had the lowest EBL (66 vs 795 vs 326 mL, P &lt;.0001). HoLEP and RSP had a lower risk of blood transfusion compared to OSP (P &lt;.0001). These associations remained significant on multivariable analyses. HoLEP is a minimally invasive treatment option for large prostates that was found to have shorter operative time, LOS, and catheter duration as well as lower EBL compared to OSP and RSP.</description><identifier>ISSN: 0090-4295</identifier><identifier>EISSN: 1527-9995</identifier><identifier>DOI: 10.1016/j.urology.2022.12.018</identifier><identifier>PMID: 36586427</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Holmium ; Humans ; Laser Therapy ; Lasers, Solid-State - therapeutic use ; Male ; Prostate - surgery ; Prostatectomy ; Prostatic Hyperplasia - surgery ; Retrospective Studies ; Robotic Surgical Procedures ; Treatment Outcome</subject><ispartof>Urology (Ridgewood, N.J.), 2023-03, Vol.173, p.180-186</ispartof><rights>2022 Elsevier Inc.</rights><rights>Copyright © 2022 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-b1aa7f5d044cd5318f67d06d72fea4f256ec8811ea2db136b5758983aac3cda03</citedby><cites>FETCH-LOGICAL-c365t-b1aa7f5d044cd5318f67d06d72fea4f256ec8811ea2db136b5758983aac3cda03</cites><orcidid>0000-0003-0451-5821</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.urology.2022.12.018$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,782,786,3554,27933,27934,46004</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36586427$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, Matthew S.</creatorcontrib><creatorcontrib>Assmus, Mark A.</creatorcontrib><creatorcontrib>Ganesh, Meera</creatorcontrib><creatorcontrib>Han, Josh</creatorcontrib><creatorcontrib>Helon, Jessica</creatorcontrib><creatorcontrib>Mai, Quan</creatorcontrib><creatorcontrib>Mi, Xinlei</creatorcontrib><creatorcontrib>Krambeck, Amy E.</creatorcontrib><title>An Outcomes Comparison Between Holmium Laser Enucleation of the Prostate, Open Simple Prostatectomy, and Robotic Simple Prostatectomy for Large Gland Benign Prostatic Hypertrophy</title><title>Urology (Ridgewood, N.J.)</title><addtitle>Urology</addtitle><description>To compare perioperative outcomes between Holmium laser enucleation of the prostate (HoLEP), open simple prostatectomy (OSP), and robotic simple prostatectomy (RSP) for large prostates (&gt; 80 cc). A retrospective study of 340 patients who underwent HoLEP (n = 209), OSP (n = 66), or RSP (n = 65) at a large academic medical center between January 2013 – September 2021 was performed. Length of stay (LOS), operative time, catheter duration, estimated blood loss (EBL), blood transfusion, and 30-day ED visits and readmissions were compared between the three groups. Univariate analyses consisted of ANOVA with Tukey's corrections and Chi-square tests. Linear and multivariate logistic regression was also performed. All tests were two-sided and a p-value &lt;0.05 was pre-determined to be statistically significant. Analyses were performed with SAS v9.4. HoLEP was found to have the shortest: operative time (1.4 vs 2.7 vs 3.8h), LOS (0.65 vs 4.2 vs 2.6d), and catheter duration (0.38 vs 9.9 vs 11.2d) compared to OSP and RSP, respectively (all P &lt;.0001). HoLEP also had the lowest EBL (66 vs 795 vs 326 mL, P &lt;.0001). HoLEP and RSP had a lower risk of blood transfusion compared to OSP (P &lt;.0001). These associations remained significant on multivariable analyses. HoLEP is a minimally invasive treatment option for large prostates that was found to have shorter operative time, LOS, and catheter duration as well as lower EBL compared to OSP and RSP.</description><subject>Holmium</subject><subject>Humans</subject><subject>Laser Therapy</subject><subject>Lasers, Solid-State - therapeutic use</subject><subject>Male</subject><subject>Prostate - surgery</subject><subject>Prostatectomy</subject><subject>Prostatic Hyperplasia - surgery</subject><subject>Retrospective Studies</subject><subject>Robotic Surgical Procedures</subject><subject>Treatment Outcome</subject><issn>0090-4295</issn><issn>1527-9995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc9u1DAQxi0EokvhEUA-cmiC7cROckLtqnSRVlrEn7Pl2JOtV0kcbKcor8UT4mW3cEHiNNLo9803Mx9CrynJKaHi3SGfvevdfskZYSynLCe0foJWlLMqa5qGP0UrQhqSlazhF-hFCAdCiBCieo4uCsFrUbJqhX5ej3g3R-0GCHjthkl5G9yIbyD-ABjxxvWDnQe8VQE8vh1n3YOKNhGuw_Ee8CfvQlQRrvBuSvwXO0z9366ObliusBoN_uxaF63-J4E755OF3wO-64_wDYx2Pz5CSbVZJvDRu-l-eYmedaoP8OpcL9G3D7df15tsu7v7uL7eZjqdF7OWKlV13JCy1IYXtO5EZYgwFetAlR3jAnRdUwqKmZYWouUVr5u6UEoX2ihSXKK3p7mTd99nCFEONmjo04Lg5iBZxZtG0IrWCeUnVKeFg4dOTt4Oyi-SEnmMSx7kOS55jEtSJslv3ZuzxdwOYP6oHvNJwPsTAOnQBwteBm1h1GCsT6-Txtn_WPwCibmt6A</recordid><startdate>202303</startdate><enddate>202303</enddate><creator>Lee, Matthew S.</creator><creator>Assmus, Mark A.</creator><creator>Ganesh, Meera</creator><creator>Han, Josh</creator><creator>Helon, Jessica</creator><creator>Mai, Quan</creator><creator>Mi, Xinlei</creator><creator>Krambeck, Amy E.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0451-5821</orcidid></search><sort><creationdate>202303</creationdate><title>An Outcomes Comparison Between Holmium Laser Enucleation of the Prostate, Open Simple Prostatectomy, and Robotic Simple Prostatectomy for Large Gland Benign Prostatic Hypertrophy</title><author>Lee, Matthew S. ; Assmus, Mark A. ; Ganesh, Meera ; Han, Josh ; Helon, Jessica ; Mai, Quan ; Mi, Xinlei ; Krambeck, Amy E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-b1aa7f5d044cd5318f67d06d72fea4f256ec8811ea2db136b5758983aac3cda03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Holmium</topic><topic>Humans</topic><topic>Laser Therapy</topic><topic>Lasers, Solid-State - therapeutic use</topic><topic>Male</topic><topic>Prostate - surgery</topic><topic>Prostatectomy</topic><topic>Prostatic Hyperplasia - surgery</topic><topic>Retrospective Studies</topic><topic>Robotic Surgical Procedures</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Matthew S.</creatorcontrib><creatorcontrib>Assmus, Mark A.</creatorcontrib><creatorcontrib>Ganesh, Meera</creatorcontrib><creatorcontrib>Han, Josh</creatorcontrib><creatorcontrib>Helon, Jessica</creatorcontrib><creatorcontrib>Mai, Quan</creatorcontrib><creatorcontrib>Mi, Xinlei</creatorcontrib><creatorcontrib>Krambeck, Amy E.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Urology (Ridgewood, N.J.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Matthew S.</au><au>Assmus, Mark A.</au><au>Ganesh, Meera</au><au>Han, Josh</au><au>Helon, Jessica</au><au>Mai, Quan</au><au>Mi, Xinlei</au><au>Krambeck, Amy E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An Outcomes Comparison Between Holmium Laser Enucleation of the Prostate, Open Simple Prostatectomy, and Robotic Simple Prostatectomy for Large Gland Benign Prostatic Hypertrophy</atitle><jtitle>Urology (Ridgewood, N.J.)</jtitle><addtitle>Urology</addtitle><date>2023-03</date><risdate>2023</risdate><volume>173</volume><spage>180</spage><epage>186</epage><pages>180-186</pages><issn>0090-4295</issn><eissn>1527-9995</eissn><abstract>To compare perioperative outcomes between Holmium laser enucleation of the prostate (HoLEP), open simple prostatectomy (OSP), and robotic simple prostatectomy (RSP) for large prostates (&gt; 80 cc). A retrospective study of 340 patients who underwent HoLEP (n = 209), OSP (n = 66), or RSP (n = 65) at a large academic medical center between January 2013 – September 2021 was performed. Length of stay (LOS), operative time, catheter duration, estimated blood loss (EBL), blood transfusion, and 30-day ED visits and readmissions were compared between the three groups. Univariate analyses consisted of ANOVA with Tukey's corrections and Chi-square tests. Linear and multivariate logistic regression was also performed. All tests were two-sided and a p-value &lt;0.05 was pre-determined to be statistically significant. Analyses were performed with SAS v9.4. HoLEP was found to have the shortest: operative time (1.4 vs 2.7 vs 3.8h), LOS (0.65 vs 4.2 vs 2.6d), and catheter duration (0.38 vs 9.9 vs 11.2d) compared to OSP and RSP, respectively (all P &lt;.0001). HoLEP also had the lowest EBL (66 vs 795 vs 326 mL, P &lt;.0001). HoLEP and RSP had a lower risk of blood transfusion compared to OSP (P &lt;.0001). These associations remained significant on multivariable analyses. HoLEP is a minimally invasive treatment option for large prostates that was found to have shorter operative time, LOS, and catheter duration as well as lower EBL compared to OSP and RSP.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>36586427</pmid><doi>10.1016/j.urology.2022.12.018</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-0451-5821</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0090-4295
ispartof Urology (Ridgewood, N.J.), 2023-03, Vol.173, p.180-186
issn 0090-4295
1527-9995
language eng
recordid cdi_proquest_miscellaneous_2759961718
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Holmium
Humans
Laser Therapy
Lasers, Solid-State - therapeutic use
Male
Prostate - surgery
Prostatectomy
Prostatic Hyperplasia - surgery
Retrospective Studies
Robotic Surgical Procedures
Treatment Outcome
title An Outcomes Comparison Between Holmium Laser Enucleation of the Prostate, Open Simple Prostatectomy, and Robotic Simple Prostatectomy for Large Gland Benign Prostatic Hypertrophy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-11-30T06%3A29%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20Outcomes%20Comparison%20Between%20Holmium%20Laser%20Enucleation%20of%20the%20Prostate,%20Open%20Simple%20Prostatectomy,%20and%20Robotic%20Simple%20Prostatectomy%20for%20Large%20Gland%20Benign%20Prostatic%20Hypertrophy&rft.jtitle=Urology%20(Ridgewood,%20N.J.)&rft.au=Lee,%20Matthew%20S.&rft.date=2023-03&rft.volume=173&rft.spage=180&rft.epage=186&rft.pages=180-186&rft.issn=0090-4295&rft.eissn=1527-9995&rft_id=info:doi/10.1016/j.urology.2022.12.018&rft_dat=%3Cproquest_cross%3E2759961718%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2759961718&rft_id=info:pmid/36586427&rft_els_id=S0090429522010822&rfr_iscdi=true